EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab

Yuki Satake, Shunsuke Sakai, Tetsuro Takao, Takako Saeki iD

Modern Rheumatology Case Reports · 2024

DOI: 10.1093/mrcr/rxad071 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2024. Verfasst von Yuki Satake und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata, Japan. Hauptthemen laut MEDLINE: Cyclophosphamide, Subarachnoid Hemorrhage, Glucocorticoids, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Subarachnoid haemorrhage (SAH) is a quite rare but serious central nervous system complication of eosinophilic granulomatosis with polyangiitis (EGPA). We report a case of myeloperoxidase antineutrophil cytoplasmic antibody–positive EGPA in which SAH developed during glucocorticoid induction pulse therapy for skin purpura, peripheral neuropathy, and rapidly progressive glomerulonephritis. In addition to high-dose glucocorticoid and intravenous cyclophosphamide, we administered mepolizumab, a humanised anti-interleukin-5 monoclonal antibody, and this resulted in remission of the SAH. Although the pathogenesis of SAH in EGPA is not fully understood, both necrotising vasculitis and eosinophilic inflammation are thought to be involved. In addition to prompt intensive immunosuppressive therapy, mepolizumab should be considered for SAH associated with EGPA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideSubarachnoid HemorrhageGlucocorticoidsAntibodies, Monoclonal, HumanizedAntibodies, Antineutrophil CytoplasmicImmunosuppressive AgentsHumansTreatment OutcomeChurg-Strauss SyndromePeroxidaseGranulomatosis with PolyangiitisMaleDrug Therapy, CombinationMiddle AgedFemale

Stichwörter der Autor:innen

Eosinophilic granulomatosis with polyangiitisMPO-ANCAmepolizumabsubarachnoid haemorrhage

Substanzen

CyclophosphamideGlucocorticoidsmepolizumabAntibodies, Monoclonal, HumanizedAntibodies, Antineutrophil CytoplasmicImmunosuppressive AgentsPeroxidase

Autor:innen und Institutionen

  • Department of Internal Medicine, Nagaoka Red Cross Hospital, Niigata, Japan.
  • Department of Neurosurgery, Nagaoka Red Cross Hospital, Niigata, Japan.

ORCID-Profile: Takako Saeki

Zitieren

APA

Satake, Y., Sakai, S., Takao, T., & Saeki, T. (2024). A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxad071

Vancouver

Satake Y, Sakai S, Takao T, Saeki T. A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab. Modern Rheumatology Case Reports. 2024. doi:10.1093/mrcr/rxad071

BibTeX
@article{Satake2024,
  author = {Satake, Yuki and Sakai, Shunsuke and Takao, Tetsuro and Saeki, Takako},
  title = {A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab},
  journal = {Modern Rheumatology Case Reports},
  year = {2024},
  doi = {10.1093/mrcr/rxad071}
}
Kostenlos starten →